Attogene Corporation

Austin, TX Doing business as Attogene Corp

UEI
M5VSPH6FK6D6
CAGE
5K6J2
Primary NAICS
541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Self Certified Small Disadvantaged Business
  • For Profit Organization
  • Manufacturer of Goods
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
3913 Todd Ln #310, Austin, TX 78744, USA
Website
attogene.com
Founded
2012
Employees
1-10
Estimated annual revenue
$0-$1M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Biotechnology
SIC code
87 Engineering & Management Services
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

About Attogene Corporation

Attogene Corporation is a biotechnology company based in Austin, Texas, registered in SAM.gov since 2010 and classified as a self-certified small disadvantaged business, for-profit organization, and manufacturer of goods. The company specializes in developing innovative diagnostic and detection technologies, with a focus on creating rapid, portable, and sensitive testing solutions for various environmental and biomedical applications. As a small business, Attogene Corp has successfully secured multiple federal grant awards from key scientific research agencies, demonstrating its capacity to develop cutting-edge technological solutions addressing critical public health and environmental challenges.

The company has been awarded several significant federal grants from agencies like the National Institute of Environmental Health Sciences (NIEHS) and the National Institute of General Medical Sciences (NIGMS), focusing on developing advanced detection and screening technologies. These grants include a $257,312 project to create a novel electrochemical biosensor for detecting organophosphate and carbamate pesticides, a $229,975 grant to develop a rapid lateral flow assay for detecting ribonucleases in RNA-based therapeutic manufacturing, and another grant to create a screening test for dihydroanatoxin-A, a toxin derived from cyanobacteria. Each project shares a common theme of developing portable, cost-effective, and rapid testing methodologies that can be used in field settings, laboratories, and manufacturing environments. The grants primarily support Phase I research and development efforts, with completion dates ranging from August 2024 to June 2026, indicating Attogene Corporation's ongoing commitment to innovative scientific research and technological solution development.

Quick answers

What is Attogene Corporation's UEI?

Attogene Corporation's Unique Entity ID (UEI) in SAM.gov is M5VSPH6FK6D6.

What is Attogene Corporation's CAGE code?

Attogene Corporation's CAGE code is 5K6J2.

What is Attogene Corporation's primary NAICS code?

Attogene Corporation's primary NAICS code is 541715 (Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)).

Where is Attogene Corporation located?

Attogene Corporation's physical address in SAM.gov is 3913 Todd Ln #310, Austin, TX 78744, USA.

Is Attogene Corporation registered in SAM.gov?

Yes. Attogene Corporation's SAM.gov registration is active through June 8, 2027.

What is Attogene Corporation's most recent federal award?

Attogene Corporation's most recent federal grant award is Development of a novel electrochemical pesticide sensor - project summary/abstract organophosphate and carbamate… (R43ES038029), from National Institute of Environmental Health Sciences, on August 26, 2025.

On GovTribe

See Attogene Corporation's full federal record

  • Federal contract awards
  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors